Search Results

• • 18 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training

  Authors:Anthony F Yu and Lee W JonesFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20159,850 words Report 1980LAuthor(s): Anthony F Yu aff1 , Lee W Jones [*] aff1 KEYWORDS aerobic training; anthracycline; cardiotoxicity; exercise; Hodgkin lymphoma; mediastinal radiotherapy Hodgkin lymphoma (HL) is now a curable disease...

• Malignant cardiac tumors: diagnosis and treatment.

  Authors:Chiara Lestuzzi, Antonino De Paoli, Tanja Baresic, Gianmaria Miolo, and Angela BuonadonnaFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20159,172 words Report 1650LPrimary malignant cardiac tumors are represented by sarcomas and non-Hodgkin lymphomas. They are rare, affect mostly patients in the fourth decade of life and have a severe prognosis. Both the diagnosis and the treatment...

• Current and emerging modalities for detection of cardiotoxicity in cardio-oncology

  Authors:Michel G Khouri, Michael R Klein, Eric J Velazquez, and Lee W JonesFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 201510,290 words Report 2330LAuthor(s): Michel G Khouri [*] aff1 , Michael R Klein aff1 , Eric J Velazquez aff1 , Lee W Jones aff2 KEYWORDS anthracyclines; biomarkers; cardiotoxicity; chemotherapy; echocardiography; imaging; stress testing;...

• Caring for cancer survivors: more than just checking the blood pressure and measuring the ejection fraction

  Authors:Daniel A Mulrooney and Daniel A DuprezFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20152,823 words Editorial 1820LAuthor(s): Daniel A Mulrooney [*] aff1 aff2 , Daniel A Duprez aff3 KEYWORDS: arterial stiffness; atherosclerosis; blood pressure; cancer survivors; cardiovascular disease; ejection fraction; endothelial...

• Strain imaging to detect cancer therapeutics-related cardiac dysfunction: are we there yet?

  Authors:Patrick Collier, Srikanth Koneru, Balaji Tamarappoo, and Brian GriffinFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20153,061 words Report 2040LAuthor(s): Patrick Collier [*] aff1 , Srikanth Koneru aff1 , Balaji Tamarappoo aff1 , Brian Griffin aff1 KEYWORDS: cancer therapeutics-related cardiac dysfunction; cardio-oncology; echo; radiation heart disease;...

• Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern

  Authors:Jannet C Beukema, Johannes A Langendijk, and Christina T MuijsFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20151,801 words Editorial 1800LAuthor(s): Jannet C Beukema [*] aff1 , Johannes A Langendijk aff1 , Christina T Muijs aff1 KEYWORDS: cardiac toxicity; esophageal cancer; radiotherapy The number of patients with esophageal cancer treated with...

• Managing anthracycline-induced cardiotoxicity: beginning with the end in mind

  Authors:Emanuela Salvatorelli, Pierantonio Menna, and Giorgio MinottiFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20152,451 words Editorial 2100LAuthor(s): Emanuela Salvatorelli aff1 , Pierantonio Menna aff1 aff2 , Giorgio Minotti [*] aff1 aff2 KEYWORDS: Anthracyclines; cardiotoxicity; comorbidities; dexrazoxane; doxorubicin; heart failure; prevention;...

• Heart failure and chemotherapeutic agents

  Authors:Susan Piper and Theresa McDonaghFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 201511,859 words Report 1810LAuthor(s): Susan Piper [*] aff1 aff2 , Theresa McDonagh aff1 aff2 KEYWORDS anthracyclines; cardiotoxicity; chemotherapy; heart failure; left ventricular systolic dysfunction; trastuzumab Over the past 20 years,...

• Heart failure years after cancer treatment

  Authors:Nieves Montoro and Jose Luis Lopez-SendonFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20154,831 words Report 2030LAuthor(s): Nieves Montoro [*] aff1 , Jose Luis López-Sendón aff1 KEYWORDS cardiotoxicity; heart failure; left ventricular dysfunction The development of cancer treatment in the past 30 years has resulted in an...

• Cardiotoxicity from the cardiologist's perspective

  Authors:Juan Caro Codon, Sandra O Rosillo Rodriguez, and Teresa Lopez FernandezFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20154,497 words Report 1880LAuthor(s): Juan Caro Codón aff1 , Sandra O Rosillo Rodríguez aff1 , Teresa López Fernández [*] aff1 KEYWORDS anthracyclines; biomarkers; cardiotoxicity; chemotherapy; diagnosis; echocardiography; global...

• Building a cardio-oncology program in a small- to medium-sized, nonprimary cancer center, academic hospital in the USA: challenges and pitfalls

  Authors:Tochi M Okwuosa, Nausheen Akhter, Kim A Williams, and Jeanne M DeCaraFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20154,622 words Report 1670LAuthor(s): Tochi M Okwuosa [*] aff1 , Nausheen Akhter aff2 , Kim A Williams aff1 , Jeanne M DeCara aff3 KEYWORDS: cancer; cardiology; cardio-oncology; chemotherapy; clinic; epidemiology; oncocardiology; patient;...

• Erratum

  From:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 201594 words Brief article, Corre... 1560LFollowing publication of the Review by David Rohde, Martin Busch, Anne Volkert, Julia Ritterhoff, Hugo A Katus, Karsten Peppel & Patrick Most, titled 'Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's...

• Arrhythmic complications of tyrosine kinase inhibitors

  Authors:Michael G Fradley and Javier Pinilla-IbarzFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20153,306 words Report 1730LAuthor(s): Michael G Fradley [*] aff1 , Javier Pinilla-Ibarz aff2 KEYWORDS: arrhythmia; atrial fibrillation; cancer treatment; cardiotoxicity; chemotherapy; QT prolongation; Torsades de Pointes; tyrosine kinase...

• Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity

  Author:Eugene StorozynskyFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20152,444 words Report 1870LAuthor(s): Eugene Storozynsky [*] aff1 KEYWORDS: biomarkers; cardiotoxicity; chemotherapy; heart failure; imaging; SERCA 2 Chemotherapy-induced cardiotoxicity has been recognized over the last several decades...

• Improving prediction of cardiovascular complications of cancer therapy: what does the future hold?

  Author:Ana BaracFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20153,192 words Report 2160LAuthor(s): Ana Barac [*] aff1 KEYWORDS: biomarkers; cancer treatment; cardiac imaging; cardiotoxicity; cardiovascular outcomes; cardiovascular risk models; targeted therapeutics "Prediction is very difficult,...

• The link between lipids, statins and cancer: is there a role for cardio-oncology?

  Authors:Eiman Jahangir, Nichole M Polin, Carl J Lavie, and Sergio FazioFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20153,127 words Report 1790LAuthor(s): Eiman Jahangir [*] aff1 , Nichole M Polin aff1 , Carl J Lavie aff1 , Sergio Fazio aff2 KEYWORDS: cancer; cardio-oncology; cholesterol; HMG-CoA reductase inhibitors; lipids; statins As the field of...

• Cardio-oncology: a new discipline in medicine to lead us into truly integrative care

  Authors:Ellen Clarke and Daniel LenihanFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20151,467 words Article 2110LAuthor(s): Ellen Clarke aff1 , Daniel Lenihan [*] aff2 KEYWORDS: advanced imaging; biomarkers; cardio-oncology; cardiotoxicity This themed issue of Future Cardiology , guest edited by Daniel Lenihan and Steven...

• The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy

  Authors:Amy M Berkman and Susan G LakoskiFrom:Future Cardiology (Vol. 11, Issue 4) Peer-Reviewed

  July 20153,706 words Report 2310LAuthor(s): Amy M Berkman [*] aff1 , Susan G Lakoski aff2 aff3 KEYWORDS: cancer; cardiorespiratory fitness; cardiotoxicity; cardiovascular disease; exercise training The use of particular chemotherapeutic...